REPORTS

Global Biologics and Biosimilars Market Size study, by Type(Antibody, Hormone, Growth Factors), by Applications (Tumor, Diabetes, Cardiovascular, Hemophilia, Other), by and Regional Forecasts 2018-2025

Publishing Date : 21 Nov 2018 Report Code : bizwit_1887 Pages : 200 Category : Healthcare and Pharma
Description

Global Biologics and Biosimilars Market to reach USD xxx billion by 2025. Global Biologics and Biosimilars Market valued approximately USD xxx billion in 2017 is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2018-2025. The Biologics and Biosimilars market is developing and expanding at a significant pace. The Biologics are mainly the medicines which are made from living cells through an highly complex manufacturing processes & must be administered and monitored under careful conditions. The Biologics are precisely utilized to prevent, diagnose, Treat and cure a variety of chronic and infectious diseases which mainly include Chronic Kidney Diseases, Cancer and autoimmune diseases. The biosimilar is exactly what its name implies that it is a biologic which is similar to another biologic drug which has been already approved by the Food & Drug Administration (FDA). In the present scenario, under United States Law, a biosimilar is specifically approved based on a showing that is highly similar to an already FDA approved biological product which is commonly known as reference product. It could not have an clinically meaningful differences in terms of safety & effectiveness from the reference product. The demand of Biologics and biosimilar is on the constant rise owing to the factors which includes rise in the prevalence of chronic and infectious diseases such as Cancer and Cardiovascular diseases, surge in the geriatric population, novel research & development advanced drugs along with escalating number of clinical trails on the globe. However, the manufacturing concerns or issues owing to complexity of drug molecules are hindering the growth of market. The surge in the research & development investments and activities considering the field of pharmaceuticals along with increase in the therapeutical applications are expected to offer new opportunities for the growth of biologics and biosimilars market on the global scenario. The regional analysis of Global Biologics and Biosimilars Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the fastest growing region across the world in terms of market share. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is anticipated to be the dominating region over the forecast period 2018-2025. The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: By Type: Antibody Hormone Growth Factors Other By Applications: Tumor Diabetes Cardiovascular Haemophilia Other By Regions: North America o U.S. o Canada Europe o UK o Germany Asia Pacific o China o India o Japan Latin America o Brazil o Mexico Rest of the World Furthermore, years considered for the study are as follows: Historical year - 2015, 2016 Base year - 2017 Forecast period - 2018 to 2025 The leading market players mainly include- Roche Amgen AbbVie Sanofi-Aventis Johnson & Johnson Pfizer Novo Nordisk Eli Lily Novartis Merck Dong Bao Ganlee United Laboratories Target Audience of the Global Biologics and Biosimilars Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture capitalists Value-Added Resellers (VARs) Third-party knowledge providers Investment bankers Investors

Table of Figures

TABLE OF CONTENTS Chapter 1. Global Biologics and Biosimilars Market Definition and Scope 1.1. Research Objective 1.2. Market Definition 1.3. Scope of The Study 1.4. Years Considered for The Study 1.5. Currency Conversion Rates 1.6. Report Limitation Chapter 2. Research Methodology 2.1. Research Process 2.1.1. Data Mining 2.1.2. Analysis 2.1.3. Market Estimation 2.1.4. Validation 2.1.5. Publishing 2.2. Research Assumption Chapter 3. Executive Summary 3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion) 3.2. Key Trends Chapter 4. Global Biologics and Biosimilars Market Dynamics 4.1. Growth Prospects 4.1.1. Drivers 4.1.2. Restraints 4.1.3. Opportunities 4.2. Industry Analysis 4.2.1. Porter's 5 Force Model 4.2.2. PEST Analysis 4.2.3. Value Chain Analysis 4.3. Analyst Recommendation & Conclusion Chapter 5. Global Biologics and Biosimilars Market, By Type 5.1. Market Snapshot 5.2. Market Performance - Potential Model 5.3. Global Biologics and Biosimilars Market, Sub Segment Analysis 5.3.1. Antibody 5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 5.3.2. Hormone 5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 5.3.3. Growth Factors 5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 5.3.4. Other 5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion) 5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 6. Global Biologics and Biosimilars Market, By Applications 6.1. Market Snapshot 6.2. Market Performance - Potential Model 6.3. Global Biologics and Biosimilars Market, Sub Segment Analysis 6.3.1. Tumor 6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 6.3.2. Diabetes 6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 6.3.3. Cardiovascular 6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion) 6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 6.3.4. Hemophilia 6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion) 6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) 6.3.5. Other 6.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion) 6.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 7. Global Biologics and Biosimilars Market, by Regional Analysis 7.1. Biologics and Biosimilars Market, Regional Market Snapshot (2015-2025) 7.2. North America Biologics and Biosimilars Market Snapshot 7.2.1. U.S. 7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.2.1.3. Technology breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.2.2. Canada 7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.2.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.3. Europe Biologics and Biosimilars Market Snapshot 7.3.1. U.K. 7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.3.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.3.2. Germany 7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.3.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.3.3. France 7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.3.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.3.4. Rest of Europe 7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.3.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.4. Asia Biologics and Biosimilars Market Snapshot 7.4.1. China 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.4.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.4.2. India 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.4.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.4.3. Japan 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.4.3.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.4.4. Rest of Asia Pacific 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.4.4.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.5. Latin America Biologics and Biosimilars Market Snapshot 7.5.1. Brazil 7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.5.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.5.2. Mexico 7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.5.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.6. Rest of The World 7.6.1. South America 7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.6.1.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.6.2. Middle East and Africa 7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion) 7.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion) 7.6.2.3. Applications breakdown estimates & forecasts, 2015-2025 (USD Billion) Chapter 8. Competitive Intelligence 8.1. Company Market Share (Subject to Data Availability) 8.2. Top Market Strategies 8.3. Company Profiles 8.3.1. Roche 8.3.1.1. Overview 8.3.1.2. Financial (Subject to Data Availability) 8.3.1.3. Product Summary 8.3.1.4. Recent Developments 8.3.2. Amgen 8.3.3. AbbVie 8.3.4. Sanofi-Aventis 8.3.5. Johnson & Johnson 8.3.6. Pfizer 8.3.7. Novo Nordisk 8.3.8. Eli Lily 8.3.9. Novartis 8.3.10. Merck 8.3.11. Biotech 8.3.12. Gelgen 8.3.13. Innovent 8.3.14. Ganlee 8.3.15. United Laboratories